Treatment of acute myelogenous leukemia in older adults

被引:53
作者
Rowe, JM
机构
[1] Rambam Med Ctr, Dept Hematol & Bone Marrow Transplantat, IL-31093 Haifa, Israel
[2] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel
[3] Univ Rochester, Sch Med & Dent, Rochester, NY USA
关键词
acute myelogenous leukemia; older adults;
D O I
10.1038/sj.leu.2401539
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:480 / 487
页数:8
相关论文
共 68 条
  • [1] Treatment of refractory and relapsed acute myelogenous leukemia with combination chemotherapy plus the multidrug resistance modulator PSC833 (Valspodar)
    Advani, R
    Saba, HI
    Tallman, MS
    Rowe, JM
    Wiernik, PH
    Ramek, J
    Dugan, K
    Lum, B
    Villena, J
    Davis, E
    Paietta, E
    Litchman, M
    Sikic, BI
    Greenberg, PL
    [J]. BLOOD, 1999, 93 (03) : 787 - 795
  • [2] [Anonymous], 1998, Br J Haematol, V103, P100
  • [3] ARCECI RJ, 1993, BLOOD, V81, P2215
  • [4] ARLIN Z, 1990, LEUKEMIA, V4, P177
  • [5] Granulocyte colony-stimulating factor (G-CSF, filgrastim) after or during an intensive remission induction therapy for adult acute lymphoblastic leukaemia: Effects, role of patient pretreatment characteristics, and costs
    Bassan, R
    Lerede, T
    DiBona, E
    Rossi, G
    Pogliani, E
    Rambaldi, A
    Buelli, M
    Viero, P
    Rodeghiero, F
    Izzi, T
    Corneo, G
    Barbui, T
    [J]. LEUKEMIA & LYMPHOMA, 1997, 26 (1-2) : 153 - 161
  • [6] Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients (>55 to 70 years of age) with acute myelogenous leukemia
    Bennett, CL
    Stinson, TJ
    Tallman, MS
    Stadtmauer, EA
    Marsh, RW
    Friedenberg, W
    Lazarus, HM
    Kaminer, L
    Golub, RM
    Rowe, JM
    [J]. ANNALS OF ONCOLOGY, 1999, 10 (02) : 177 - 182
  • [7] Economic analyses in clinical trials for cooperative groups: Operational considerations
    Bennett, CL
    Waters, TM
    [J]. CANCER INVESTIGATION, 1997, 15 (05) : 448 - 453
  • [8] Economic analyses of phase III cooperative cancer group clinical trials: Are they feasible?
    Bennett, CL
    Golub, R
    Waters, TM
    Tallman, MS
    Rowe, JM
    [J]. CANCER INVESTIGATION, 1997, 15 (03) : 227 - 236
  • [9] BERMAN E, 1991, BLOOD, V77, P1666
  • [10] BERMAN E, 1989, LEUKEMIA, V3, P115